Could a Head-Zap device lift depression without drugs?

NCT ID NCT05539131

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested whether a device called transcranial direct current stimulation (tDCS) can help people with mild to moderate depression. The device sends a tiny electrical current through the scalp to regulate brain activity. Researchers enrolled 198 adults and measured changes in depression symptoms using standard questionnaires. The goal was to see if tDCS works in real-world clinics and could eventually be used at home.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) device
What this could lead to
If it works, this could offer a non-drug, at-home option to help ease depression symptoms.
What could go wrong
This is a completed demonstration study, not a large late-phase trial. The results may not apply to everyone, and the device may not work for all types of depression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Catholic Kwandong University International St. Mary'S Hospital

    Incheon, Gyeonggi-do, 22711, South Korea

  • Hallym Univsity Chuncheon Sacred Heart Hospital

    Chuncheon, Gangwon-do, 24253, South Korea

  • Myongji Hospital

    Goyang-si, Gyeonggi-do, 10475, South Korea

  • National Health Insurance Service Ilsanhospital

    Goyang-si, Gyeonggi-do, 10444, South Korea

  • Yongin Severance Hospital, Yonsei University College of Medicine

    Yongin, Gyeonggi-do, 16995, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.